查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1733393

全球煙醯胺腺嘌呤二核苷酸（NAD）市場：市場規模（按類型、應用和地區）、未來預測

Global Nicotinamide Adenine Dinucleotide (NAD) Market Size By Type (Pharmaceutical Grade, Food Grade), By Application (Dietary Supplement, Pharmaceutical Industry), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

煙醯胺腺嘌呤二核苷酸（NAD）市場規模及預測

煙醯胺腺嘌呤二核苷酸 (NAD) 市場規模在 2024 年價值 4.94 億美元，預計到 2032 年將達到 8.734 億美元，在預測期內（2026-2032 年）的複合年成長率為 14%。

NAD 用於催化化學反應，不僅產生能量，而且建造和修復構成我們身體的分子。 「全球煙醯胺腺嘌呤二核苷酸 (NAD) 市場」報告對市場進行了全面評估。它對關鍵細分市場、趨勢、市場促進因素、限制因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

定義全球煙醯胺腺嘌呤二核苷酸（NAD）市場

煙醯胺腺嘌呤二核苷酸 (NAD+) 是一種關鍵的吡啶核苷酸，是涉及氧化磷酸化和 ATP 生成、DNA 修復、表觀遺傳調控的基因表現表現、細胞內鈣訊號傳導和免疫功能的幾種關鍵細胞基材的必需輔酶和底物。顧名思義，它是由兩種核苷酸組成的，即腺嘌呤和煙醯胺。它們透過磷酸基團連接在一起。一般來說，NAD以氧化型和還原型兩種形式存在，分別縮寫為NAD+和NADH。此外，NAD 也可作為抗衰老的重要輔助手段。

現代生物學研究中最知名的 NAD 補充劑之一是 NADH，它是一種粒線體激素，其功能是提高細胞活力（抗衰老）。此外，NAD+ 主要用於分解代謝途徑，與糖解作用一起分解能量分子以產生 ATP。所有活細胞的細胞呼吸過程都利用輔酶煙醯胺腺嘌呤二核苷酸 (NAD)。煙醯胺腺嘌呤二核苷酸（NAD）透過接受和捐贈電子在能量代謝中發揮關鍵作用。此外，煙醯胺腺嘌呤二核苷酸 (NAD) 增強劑可透過靶向細胞來對抗老化。這種補充劑可以促進身體抗衰老。然而，大多數 NAD+ 補充劑都含有菸鹼醯胺核糖 (NR) 或菸鹼醯胺單核苷酸 (NMN)。

全球煙醯胺腺嘌呤二核苷酸（NAD）市場概況

NAD 用於催化化學反應，不僅可以產生能量，還可以建造和修復構成我們身體的分子，這對市場需求產生影響並積極推動其成長。此外，NAD 還具有許多益處，例如幫助維持細胞健康。此外，煙醯胺腺嘌呤二核苷酸 (NAD) 增強劑可透過靶向細胞來對抗老化。此外，它還能增強免疫系統並幫助修復 DNA。它還有助於增強耐力和促進新陳代謝。因此，上述優勢將有助於創造對煙醯胺腺嘌呤二核苷酸（NAD）的需求，進而促進市場成長；此外，人口老化和不良的飲食習慣也將有助於擴大該產業的需求。

使用 NAD 可以讓您在正確的時間睡覺和吃飯，幫助市場成長。此外，世界各地人們的可支配收入不斷增加，生活方式也在改變。因此，垃圾食物消費量正在上升。因此，增加垃圾食物的攝取量會導致體內膽固醇水平失衡。預計這將刺激對藥品的需求並推動煙醯胺腺嘌呤二核苷酸 (NAD) 市場的成長。此外，NAD 可以由色氨酸和菸鹼酸產生。此外，利用菸鹼醯胺（NAD 分解產物）作為基材的 NAD 生成的「補救途徑」在哺乳動物細胞中也廣泛存在且充滿活力，並且似乎被一部分人類癌症專門利用。

因此，NAD有潛力用於治療大多數癌症。因此，全球心血管疾病的數量不斷增加，對煙醯胺腺嘌呤二核苷酸 (NAD) 產生了需求，從而推動了煙醯胺腺嘌呤二核苷酸 (NAD) 市場的成長。然而，一些研究發現，過量攝取NAD 會引起一些副作用，包括噁心皮疹、頭痛、頭暈、腹脹以及毛孔和皮膚問題，包括搔癢和出汗。因此，這些副作用可能會阻礙市場的成長。

目錄

第1章全球煙醯胺腺嘌呤二核苷酸（NAD）市場簡介

  • 市場概覽
  • 分析範圍
  • 先決條件

第2章執行摘要

第3章 已驗證的市場研究分析方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

4. 全球煙醯胺腺嘌呤二核苷酸（NAD）市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

5. 全球煙醯胺腺嘌呤二核苷酸（NAD）市場類型

  • 概述
  • 醫藥級
  • 食品級
  • 其他

6. 全球煙醯胺腺嘌呤二核苷酸（NAD）市場應用

  • 概述
  • 營養補充品
  • 製藥業
  • 其他

7. 全球煙醯胺腺嘌呤二核苷酸（NAD）市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

8. 全球煙醯胺腺嘌呤二核苷酸（NAD）市場的競爭格局

  • 概述
  • 各公司市場排名
  • 主要發展策略

第9章 公司簡介

  • Bontac Bioengineering
  • Hubei Widely Chemical Technology
  • Allergan
  • Synergy Pharmaceuticals
  • Novo Nordisk A/S
  • Oramed
  • Biocon India
  • Diabetology
  • Catalent
  • EnzymeWorks

第10章：主要趨勢

  • 產品發布/開發
  • 企業合併與收購（M&A）
  • 業務擴展
  • 夥伴關係與合作

第11章 附錄

  • 相關分析
簡介目錄
Product Code: 65555

Nicotinamide Adenine Dinucleotide (NAD) Market Size And Forecast

Nicotinamide Adenine Dinucleotide (NAD) Market size was valued at USD 494 Million in 2024 and is projected to reach USD 873.4 Million by 2032, growing at a CAGR of 14% during the forecast period 2026-2032.

NAD is used to catalyze chemical reactions that are required to both generate energy as well as build and repair the molecules that make up our bodies which affect the market demand and positively increase the growth. The Global Nicotinamide Adenine Dinucleotide (NAD) Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Nicotinamide Adenine Dinucleotide (NAD) Market Definition

Nicotinamide adenine dinucleotide (NAD+) is a vital pyridine nucleotide that serves as an essential cofactor and substrate for some of the crucial cellular processes involved in oxidative phosphorylation and ATP production, DNA repair, epigenetically modulated gene expression, intracellular calcium signaling, and immunological functions. As its name implies, it consists of 2 nucleotides one with an adenine base and the other with a nicotinamide base. They are joined by their phosphate groups. Generally, there are two types of NAD first one is oxidized, and the other is reduced form, which is abbreviated as NAD+ and NADH respectively. In addition, NAD may be used as a vital adjunctive drug against aging.

One of the most famous NAD supplements in modern biological research is NADH, a mitochondrial hormone whose function is to increase the existence cycle of cells (anti-aging). Furthermore, NAD+ is mostly utilized in catabolic pathways, together with glycolysis, that smashes down energy molecules to produce ATP. The cellular breathing processes of all living cells make use of the coenzyme Nicotinamide adenine dinucleotide (NAD). Also, it performs a key function in energy metabolism with the aid of using accepting and donating electrons. Furthermore, Nicotinamide adenine dinucleotide (NAD) boosters fight aging by targeting cells. The supplement promotes anti-aging results in the body. However, most NAD+ supplements include nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN).

Global Nicotinamide Adenine Dinucleotide (NAD) Market Overview

NAD is used to catalyze chemical reactions which are required to both generate energy as well as build and repair the molecules that make up our bodies which have an effect on the marketplace demand and positively boom the growth. In addition, there are numerous advantages are associated with NAD such as it helps in maintaining cell health. In addition, Nicotinamide adenine dinucleotide (NAD) boosters fight aging by targeting cells. Furthermore, it helps in boosting the immune system and repairing DNA. Also, it helps in increasing strength and boosting the metabolism. Thus, the above-mentioned benefits will create a demand for Nicotinamide Adenine Dinucleotide (NAD), which in turn help in boosting the marketplace growth, Furthermore, an aging populace and a poor diet will also assist in growing the demand for the industry.

The use of NAD helps you sleep and eat at the right time which drives the marketplace growth. Moreover, the increase in disposable income of human beings throughout the globe has led to changes in lifestyle. This, in turn, has boosted the consumption of junk meals. Therefore, an increase in the consumption of junk meals has caused an imbalance of levels of cholesterol in the body. This is likely to enhance the demand for medicines, thereby driving the Nicotinamide Adenine Dinucleotide (NAD) marketplace growth. Moreover, NAD may be generated from tryptophan or nicotinic acid. In addition, the "salvage pathway" of NAD production, which makes use of nicotinamide, a by-product of NAD degradation, as a substrate, is also extensively energetic in mammalian cells and looks to be extraordinarily exploited by a subset of human cancers.

Thus, NAD may be used for most cancers treatment. Therefore, a growing number of cardiovascular diseases across the world will create a demand for the Nicotinamide Adenine Dinucleotide (NAD), thereby driving the Nicotinamide Adenine Dinucleotide (NAD) marketplace growth. However, in some studies, it has been observed that excessive consumption of NAD causes some side effects which include nausea rashes, headache, dizziness, bloating, and pores and skin problems which include itching and sweating. Thus, these side effects factors may hamper the marketplace growth.

Global Nicotinamide Adenine Dinucleotide (NAD) Market Segmentation Analysis

The Global Nicotinamide Adenine Dinucleotide (NAD) Market Is Segmented On The Basis Of Type, Application And Geography.

Nicotinamide Adenine Dinucleotide (NAD) Market, By Type

  • Pharmaceutical Grade
  • Food Grade
  • Others

Nicotinamide Adenine Dinucleotide (NAD) Market, By TypeBased on Type, The market is bifurcated into Pharmaceutical Grade, Food Grade, and Others. The Pharmaceutical Grade segment is presumed to become the fastest-growing segment over the forecast period. Supplements that are made in a way to ensure an extremely excessive standard of purity and maximum absorption are certified pharmaceutical grade. In addition, pharmaceutical-grade merchandise must exceed 99% purity and not include any fillers, binders, dyes, or different inactive elements that serve as a vehicle for active substances.

  • Furthermore, there are numerous benefits are associated with a pharmaceutical-grade along with BioAvailability and Purity. For instance, increased bioavailability is a major advantage of pharmaceutical-grade supplements, which can be often made with patented technology. In addition, as mentioned, pharmaceutical-grade supplements are required to undergo thorough testing to be at least 99% pure. Thus, the above-mentioned benefits are the key factor that helps in boosting the segment growth.

Nicotinamide Adenine Dinucleotide (NAD) Market, By Application

  • Dietary Supplement
  • Pharmaceutical Industry
  • Others

Based on Application, The market is bifurcated into Dietary Supplement, Pharmaceutical Industry, and Others. Dietary supplements are anticipated to have the largest marketplace share during the forecast period. Nicotinamide adenine dinucleotide (NAD+) is an alternative form of the B3 vitamin and is acquired through the synthesis in the body or as a dietary source and supplement. It is required for over 500 enzymatic reactions and performs key roles in the regulation of almost all important biological processes. Above all, it may permit us to lead healthier and longer lives. In addition, it increases HDL levels and is used in the treatment of pellagra. Thus, demand for vitamin dietary supplements is increasing, owing to the rise in fitness awareness amongst consumers. This is driving the worldwide Nicotinamide Adenine Dinucleotide (NAD) marketplace.

Nicotinamide Adenine Dinucleotide (NAD) Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on Geography, The Global Nicotinamide Adenine Dinucleotide (NAD) Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is taking up the largest share in the Nicotinamide Adenine Dinucleotide (NAD) Market and it is estimated that the region will continue dominating the market until the next couple of years. Growing awareness related to the health benefits among the consumer is the key factor that helps in boosting the market growth in the region. In addition, a growing number of cardiovascular diseases in the region will create a demand for the Nicotinamide Adenine Dinucleotide (NAD), thereby driving the Nicotinamide Adenine Dinucleotide (NAD) marketplace growth.

Key Players

The "Global Nicotinamide Adenine Dinucleotide (NAD) Market," study report will provide a valuable insight with an emphasis on the global market, including some of the major players such as Bontac Bioengineering, Hubei Widely Chemical Technology, Allergan, Synergy Pharmaceuticals, Novo Nordisk A/S, Oramed, Biocon India, Diabetology, Catalent, and EnzymeWorks.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In December 2021, Novo Nordisk announces the completion of the Dicerna Pharmaceuticals acquisition. At the completion of the merger, Dicerna became a wholly-owned subsidiary of Novo Nordisk. The common stock of Dicerna will no longer be listed or traded on the Nasdaq Global Select Market.
  • In December 2021, Biocon Ltd partners with Tabuk Pharmaceuticals to commercialize its specialty generic medicines in the Middle East. The partnership will pave the way for Biocon's expansion into the MENA region to include Saudi Arabia, UAE, Kuwait, Qatar, Oman, and Iraq, in addition to Jordan and Lebanon. This is another important milestone for Biocon, reflecting its commitment to providing patients around the globe with affordable medications, by establishing a strong global portfolio of products, either directly, or through strategic partnerships.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Pharmaceutical Grade
  • 5.3 Food Grade
  • 5.4 Others

6 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Dietary Supplement
  • 6.3 Pharmaceutical Industry
  • 6.4 Others

7 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East And Africa

8 GLOBAL NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Bontac Bioengineering
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Hubei Widely Chemical Technology
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Allergan
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Synergy Pharmaceuticals
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Novo Nordisk A/S
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Oramed
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Biocon India
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Diabetology
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Catalent
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 EnzymeWorks
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research